Hormonal changes accompanying cigarette smoke-induced preterm births in a mouse model

Experimental Biology and Medicine

Volumn 231, Issue 8, 2006, Pages 1403-1409

  Ng, Sheung P ^a   Steinetz, Bernard G ^a   Lasano, Salamia G ^a   Zelikoff, Judith T ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Cigarette smoke; Pregnancy hormones; Preterm birth

Indexed keywords

CIGARETTE SMOKE; ESTRADIOL; PROGESTERONE; PROLACTIN; RELAXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; EXPOSURE; FEMALE; GESTATION PERIOD; HORMONE DETERMINATION; HORMONE METABOLISM; HORMONE RELEASE; LITTER SIZE; MALE; MOUSE; NONHUMAN; PREMATURE LABOR; PROGESTERONE BLOOD LEVEL; RISK FACTOR; SEX RATIO; WEIGHT GAIN;

EID: 33748310575     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020623100814     Document Type: Article

References (54)

1. Albrecht SA, Maloni JA, Thomas KK, Jones R, Halleran J, Osborne J. Smoking cessation counseling for pregnant women who smoke: scientific basis for practice for AWHONN's SUCCESS Project. J Obstet Gynecol Neonatal Nurs 33:298-305, 2004.
2. March of Dimes. Smoking during pregnancy. Wilkes-Barre, PA: March of Dimes Resource Center, 2000.
3. U.S. Department of Health and Human Services, Public Health Service. Treating tobacco use and dependence. Rockville, MD: Public Health Service, 2000.
4. Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol 5:231-241, 2000.
5. Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol 20:115-126, 1996.
6. Ventura S, Martin J, Curtin S, Mathews T. Report of final natality statistics: 1996 monthly vital statistics report, 46(11 Suppl.). Hyattsville, MD: National Center for Health Statistics, 1998.
7. Walsh RA. Effects of maternal smoking on adverse pregnancy outcomes: examination of the criteria of causation. Hum Biol 66:1059-1092, 1994.
8. Pollack H, Lantz PM, Frohna JG. Maternal smoking and adverse birth outcomes among singletons and twins. Am J Public Health 90:395-400, 2000.
9. Kyrklund-Blomberg NB, Cnattingius S. Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. Am J Obstet Gynecol 179:1051-1055, 1998.
10. Harlow BL, Frigoletto FD, Cramer DW, Evans JK, LeFevre ML, Bain RP, McNellis D, the RADIUS Study Group. Determinants of preterm delivery in low-risk pregnancies. J Clin Epidemiol 49(4):441-448, 1996.
11. Nasrat HA, Al-Hachim GM, Mahmood FA. Perinatal effects of nicotine. Biol Neonate 49:8-14, 1986.
12. Berkowitz GS, Papiernik E. Epidemiology of preterm birth. Epidemiol Rev 15(2):414-443, 1993.
13. Abel EL. Smoking during pregnancy: a review of effects on growth and development of the offspring. Human Biol 52:593-625, 1980.
14. Quigley M, Sheehan KL, Wilkes MM, Yen SSC. Effects of maternal smoking on circulating catecholamine levels and fetal heart rates. Am J Obstet Gynecol 133:685-690, 1979.
15. Brown AG, Leite RS, Strauss JF III. Mechanisms underlying "functional" progesterone withdrawal at parturition. Ann N Y Acad Sci 1034:36-49, 2004.
16. Keelan JA, Coleman M, Mitchell MD. The molecular mechanisms of term and preterm labor: recent progress and clinical implications. Clin Obstet Gynecol 40:460-478, 1997.
17. Mesiano S. Roles of estrogen and progesterone in human parturition. Front Horm Res 27:86-104, 2001.
18. Lye SJ, Ou CW, Teoh TG, Erb G, Stevens Y, Casper R, Patel FA, Challis JRG. The molecular basis of labour and tocolysis. Fetal Matern Med Rev 10:121-136, 1998.
19. Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 11(4):193-202, 2004.
20. Sherwood OD. Relaxin. In: Knobil E, Neill JD, Eds. The Physiology of Reproduction, 2nd ed. New York: Raven Press, pp861-1009, 1994.
21. Sherwood OD. Relaxin's physiological roles and other diverse actions. Endocr Rev 25:205-234, 2004.
22. Michnovicz JJ, Hershcopf RJ, Naganuma H, Bradlow HL, Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the antiestrogenic effect of cigarette smoking. N Engl J Med 315:1305-1309, 1986.
23. Tanko LB, Christiansen C. An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. Menopause 11:104-109, 2004.
24. Gocze PM, Freeman DA. Cytotoxic effects of cigarette smoke alkaloids inhibit the progesterone production and cell growth of cultured MA-10 Leydig tumor cells. Eur J Obstet Gynecol Reprod Biol 93:77-83, 2000.
25. Kapoor D, Jones TH. Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 152:491-499, 2005.
26. Weigert M, Hofstetter G, Kaipl D, Gottlich H, Krischker U, Bichler K, Poehl M, Feichtinger W. The effect of smoking on oocyte quality and hormonal parameters of patients undergoing in vitro fertilization-embryo transfer. J Assist Reprod Genet 16:287-293, 1999.
27. Salazar G, Albala C, Yáñez M, Serón-Ferré M, Vio F. Smoking effects on prolactin at the end of pregnancy. Nutr Res 15:1599-1604, 1995.
28. Steinetz BG, Gordon T, Lasano S, Horton L, Ng SP, Zelikoff JT, Nadas A, Bosland MC. The parity-related protection against breast cancer is compromised by cigarette smoke during rat pregnancy: observations on tumorigenesis and immunological defenses of the neonate. Carcinogenesis 27:1146-1152, 2006.
29. Steinetz BG, Beach VL, Kroc RL, Stasilli NR, Nussbaum RE, Nemith PJ, Dun R. Bioassay of relaxin using a reference standard: a simple and reliable method utilizing direct measurement of interpubic formation in mice. Endocrinology 67:102-115, 1960.
30. Ng SP, Silverstone AE, Lai ZW, Zelikoff JT. Effects of prenatal exposure to cigarette smoke on offspring tumor susceptibility and associated immune mechanisms. Toxicol Sci 89:135-144, 2006.
31. Sherwood OD, Crnekovic VE. Development of a homologous radioimmunoassay for rat relaxin. Endocrinology 104:893-897, 1979.
32. Florek E, Marszalek A, Biczysko W, Szymanowski K. The experimental investigations of the toxic influence of tobacco smoke affecting progeny during pregnancy. Hum Exp Toxicol 18:245-251, 1999.
33. Leichter J. Decreased birth weight and attainment of postnatal catch-up growth in offspring of rats exposed to cigarette smoke during gestation. Growth Dev Aging 59:63-66, 1995.
34. Levy A, Fraser D, Katz M, Mazor M, Sheiner E. Maternal anemia during pregnancy is an independent risk factor for low birthweight and preterm delivery. Eur J Obstet Gynecol Reprod Biol 122:182-186, 2005.
35. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 162:1108-1113, 2005.
36. Crelin ES. Prevention of innominate bone separation during pregnancy in the mouse. Proc Soc Exp Biol Med 86:22-24, 1954.
37. Steinetz, BG, Beach VL, Kroc RL. The influence of progesterone, relaxin and estrogen on some structural and functional changes in the preparturient mouse. Endocrinology 61:271-280, 1957.
38. Steinetz BG, O'Byrne E, Butler M, Hickman L. Hormonal regulation of the connective tissue of the symphysis pubis. In: Bigazzi M, Greenwood F, Gasparri F, Eds. Biology of relaxin and its role in the human. Amsterdam: Excerpta Medica, pp71-92, 1983.
39. Steinetz BG, O'Byrne EM. Speculations on the probable role of relaxin in cervical dilatation and parturition in rats. Sem Reprod Endocrinol 1:335-342, 1983.
40. Egawa M, Yasuda K, Nakajima T, Okada H, Yoshimura T, Yuri T, Yasuhara M, Nakamoto T, Nagata F, Kanzaki H. Smoking enhances oxytocin-induced rhythmic myometrial contraction. Biol Reprod 68:2274-2280, 2003.
41. Gocze PM, Porpaczy Z, Freeman DA. Effect of alkaloids in cigarette smoke on human granulosa cell progesterone synthesis and cell viability. Gynecol Endocrinol 10:223-228, 1996.
42. Miceli F, Minici F, Tropea A, Catino S, Orlando M, Lamanna G, Sagnella F, Tiberi F, Bompiani A, Mancuso S, Lanzone A, Apa R. Effects of nicotine on human luteal cells in vitro: a possible role on reproductive outcome for smoking women. Biol Reprod 72:628-632, 2005.
43. Kawai M, Swan KF, Green AE, Edwards DE, Anderson MB, Henson MC. Placental endocrine disruption induced by cadmium: effects on P450 cholesterol side-chain cleavage and 3beta-hydroxysteroid dehydrogenase enzymes in cultured human trophoblasts. Biol Reprod 67:178-183, 2002.
44. Piasek M, Laskey JW, Kostial K, Blanusa M. Assessment of steroid disruption using cultures of whole ovary and/or placenta in rat and in human placental tissue. Int Arch Occup Environ Health 75(Suppl):S36-S44, 2002.
45. Henson MC, Chedrese PJ. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp Biol Med 229:383-392, 2004.
46. Meis PJ, Society for Maternal-Fetal Medicine. 17 Hydroxyprogesterone for the prevention of preterm delivery. Obstet Gynecol 105:1128-1135, 2005.
47. Spong CY, Meis PJ, Thom EA, Sibai B, Dombrowski MP, Moawad AH, Hauth JC, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S, National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery. Am J Obstet Gynecol 193:1127-1131, 2005.
48. Di Renzo GC, Rosati A, Mattei A, Gojnic M, Gerli S. The changing role of progesterone in preterm labour. BJOG 112(Suppl 1):57-60, 2005.
49. Dodd JM, Crowther CA, Cincotta R, Flenady V, Robinson JS. Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 84:526-533, 2005.
50. Sanchez-Ramos L, Kaunitz AM, Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Obstet Gynecol 105:273-279, 2005.
51. Gorenberg D, Beharry K, Nishihara KC, Chang E, Waltzman J, Akmal A, Asrat T. Dose response of RU486 in a novel rabbit model of noninfectious preterm birth: comparative efficacy of 3 routes of administration. Am J Obstet Gynecol 192:924-931, 2005.
52. Steinetz B, O'Byrne E, Kroc RL. The role of relaxin in cervical softening during pregnancy in mammals. In: Naftolin F, Stubblefield PG, Eds. Dilation of the Uterine Cervix. New York: Raven Press, pp157-177, 1980.
53. Weiss G, Goldsmith LT. Mechanisms of relaxin-mediated premature birth. Ann N Y Acad Sci 1041:345-350, 2005.
54. Bryant-Greenwood GD, Yamamoto SY, Lowndes KM, Webster LE, Parg SS, Amano A, Bullesbach EE, Schwabe C, Millar LK. Human decidual relaxin and preterm birth. Ann N Y Acad Sci 1041:338-344, 2005.